Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Amyloid fibrils activate B-1a lymphocytes to ameliorate inflammatory brain disease.
The N-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients.
Alemtuzumab benefits hard-to-treat MS patients
Effects of 2-Chlorodeoxyadenosine (Cladribine) on Primary Rat Microglia.
Neuroprotection with glatiramer acetate: evidence from the PreCISe trial.
Impact of cladribine therapy on changes in circulating dendritic cell subsets, T cells and B cells in patients with multiple sclerosis.
T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10.
Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta-1a after intramuscular and subcutaneous administration.
Society for Neuroscience Annual Meeting
Mechanism-based CNS Disease Modeling: Applications in Neurology and Psychiatry Drug Research & Development
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options.
Multiple Sclerosis and Pregnancy: Current Considerations.
Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica.
Phase III study with teriflunomide versus placebo in patients with first clinical symptom of multiple sclerosis (TOPIC)
The scales and tales of myelination: using zebrafish and mouse to study myelinating glia.
Incidence of infusion-associated reactions with rituximab for treating multiple sclerosis: a retrospective analysis of patients treated at a US centre.
Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial.
Evaluation of pattern-reversal visual evoked potential in patients with neuromyelitis optica.
Biogen Third Quarter 2015 Revenues Increase 11% to $2.8 Billion; Company Raises 2015 Full Year Guidance
Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease.
Inflammatory cortical demyelination in early multiple sclerosis.
UCSF Seminar: "Dynamics of Retina Damage in Acute Optic Neuritis"
Launch of a phase 3 clinical trial in the treatment of Alzheimer’s disease with masitinib
Interferon β-1b directly modulates human neural stem/progenitor cell fate.
The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate.

Pages